TY - JOUR
T1 - ProT-Patch
T2 - A Smart Coated Polymeric Microneedle Enables Noninvasive Protein Delivery and Reprogramming of Epidermal Skin Identity
AU - Abbas, Attiya A.
AU - Hanif, Wildan
AU - Steer, Isobel
AU - Hasan, Erol
AU - Teenan, Oliver
AU - Akhavani, Mo
AU - Mutabagani, Khaled
AU - Almquist, Benjamin D.
AU - Higgins, Claire A.
AU - Alsulaiman, Dana
N1 - Publisher Copyright:
© 2024 The Authors. Published by American Chemical Society.
PY - 2024/11/4
Y1 - 2024/11/4
N2 - Microneedles have emerged as transformative devices for noninvasive drug delivery through skin; however, reported platforms suffer poor skin penetration, dosage inaccuracy, and/or complex fabrication. Herein, we develop and validate a smart pH-responsive polymeric microneedle (proT-patch) for efficient drug delivery to the basal epidermal layer of the skin. The microneedle base offers high stiffness, while a variable needle height design eludes the “bed of nails” effect. With its stimuli-responsiveness, the microneedle coating enables drug release under specific pH conditions, enhancing dosage accuracy and minimizing biowaste. The performance of proT-patch is validated using ex vivo human skin by delivering Wnt5a, which switches on Keratin-9 expression, and is not expressed in nonplantar skin. Administering Wnt5a-loaded proT-patch to skin enhanced Keratin-9 expression in basal epidermal keratinocytes compared to topical and unloaded controls. With its facile fabrication, versatility, and exceptional performance, proT-patch shows immense potential as a next-generation, noninvasive tool for therapeutics, cosmetics, and vaccine delivery.
AB - Microneedles have emerged as transformative devices for noninvasive drug delivery through skin; however, reported platforms suffer poor skin penetration, dosage inaccuracy, and/or complex fabrication. Herein, we develop and validate a smart pH-responsive polymeric microneedle (proT-patch) for efficient drug delivery to the basal epidermal layer of the skin. The microneedle base offers high stiffness, while a variable needle height design eludes the “bed of nails” effect. With its stimuli-responsiveness, the microneedle coating enables drug release under specific pH conditions, enhancing dosage accuracy and minimizing biowaste. The performance of proT-patch is validated using ex vivo human skin by delivering Wnt5a, which switches on Keratin-9 expression, and is not expressed in nonplantar skin. Administering Wnt5a-loaded proT-patch to skin enhanced Keratin-9 expression in basal epidermal keratinocytes compared to topical and unloaded controls. With its facile fabrication, versatility, and exceptional performance, proT-patch shows immense potential as a next-generation, noninvasive tool for therapeutics, cosmetics, and vaccine delivery.
UR - http://www.scopus.com/inward/record.url?scp=85205839036&partnerID=8YFLogxK
U2 - 10.1021/acsmaterialslett.4c01609
DO - 10.1021/acsmaterialslett.4c01609
M3 - Article
AN - SCOPUS:85205839036
SN - 2639-4979
VL - 6
SP - 4997
EP - 5005
JO - ACS Materials Letters
JF - ACS Materials Letters
IS - 11
ER -